These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6186091)

  • 1. [Experimental basis of a protocol for the pathogenetic immunotherapy of tick-borne encephalitis].
    Khozinskiĭ VV; Semenov BF
    Vopr Virusol; 1982; 27(6):692-6. PubMed ID: 6186091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic mechanisms of preventing persistence of tick-borne encephalitis virus in mice].
    Khozinskiĭ VV; Semenov BF
    Vopr Virusol; 1989; 34(5):585-90. PubMed ID: 2532810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subunit immunogen of the tick-borne encephalitis virus. The immunological characteristics of glycoprotein V3 from 2 antigenic types of tick-borne encephalitis virus].
    Chumakov MP; Rubin SG; Kusov IuIu; Semashko IV; Sal'nikov IaA
    Vopr Virusol; 1984; 29(6):701-6. PubMed ID: 6528577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the response of mice with temporary immunodepression to the administration of live or inactivated vaccine against tick-borne encephalitis].
    Vargin VV; Semenov BF
    Vopr Virusol; 1979; (1):52-7. PubMed ID: 217179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
    Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
    Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of preparations of specific and nonspecific transfer-factor on the course of experimental tick-borne encephalitis].
    Pogodina VV; Levina LS; Perepechkina NP; Mats AN
    Vopr Virusol; 1989; 34(6):689-94. PubMed ID: 2633463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Donor immunization with an inactivated concentrated purified vaccine against tick-borne encephalitis to obtain immune blood preparations].
    El'bert LB; Pervikov IuV; Grachev VP; Rusanov VM; Krokhina MA
    Vopr Virusol; 1984; 29(1):56-9. PubMed ID: 6608828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To the antigenic classification of some viruses from the tick-borne encephalitis complex by monoclonal antibodies.
    Gresíková M; Sekeyová M
    Acta Virol; 1990 Feb; 34(1):90-4. PubMed ID: 1975730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of cytokines in immunization with a vaccine against experimental tick-borne encephalitis].
    Ignat'ev GM; Otrashevskaia EV; Vorob'eva MS
    Vopr Virusol; 2003; 48(2):22-5. PubMed ID: 12924094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological and etiological aspects of a study of the Aina/1448 serotype of the tick-borne encephalitis virus].
    Pogodina VV; Bochkova NG; Levina LS; Zhezmer VIu; Meĭerova RA
    Vopr Virusol; 1981; (6):735-41. PubMed ID: 7336696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional activity of specific antibodies in patients vaccinated against tick-borne encephalitis in relation to different virus strains].
    Leonova GN; Pavlenko EV
    Vopr Virusol; 2010; 55(3):33-7. PubMed ID: 20608079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein.
    Aleshin SE; Timofeev AV; Khoretonenko MV; Zakharova LG; Pashvykina GV; Stephenson JR; Shneider AM; Altstein AD
    BMC Microbiol; 2005 Aug; 5():45. PubMed ID: 16076390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
    Morozova OV; Maksimova TG; Bakhvalova VN
    Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant subolesin does not reduce tick infection with tick-borne encephalitis virus nor protect mice against disease.
    Havlíková S; Ličková M; Ayllón N; Roller L; Kazimírová M; Slovák M; Moreno-Cid JA; Pérez de la Lastra JM; Klempa B; de la Fuente J
    Vaccine; 2013 Mar; 31(12):1582-9. PubMed ID: 23357197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of macrophages in the pathogenesis of experimental tick-borne encephalitis in mice.
    Khozinsky VV; Semenov BF; Gresíková M; Chunikhin SP; Sekeyová M; Kozuch O
    Acta Virol; 1985 May; 29(3):194-202. PubMed ID: 2864820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.